SUMMARY A prospective 24 week study of 31 patients with active rheumatoid arthritis (18 women, 13 men) was undertaken to determine whether weekly intramuscular sodium aurothiomalate (gold) would influence delayed type cutaneous hypersensitivity (DTH) and other indices of cell mediated immunity. DTH to seven recall antigens was measured by Multitest on three occasions during the study. Twenty five patients completed the study. At entry 13 patients (12 female) were anergic, and no significant correlations were found between DTH and other clinical and immunological indices. Women showed a significantly greater depression of DTH than men. At week 24 only three of the patients were anergic with significant increase in mean DTH score being noted particularly to tuberculin, candida, and streptococcus. Improvement in DTH was observed in both gold responders and non-responders. In conclusion, patients with active rheumatoid arthritis show impairment of DTH, which is reversed by chrysotherapy. This effect is most apparent in women and appears to be relatively independent of the clinical response.
Many defects in various aspects of cell mediated immunity have been described in rheumatoid arthritis (RA).l Delayed type cutaneous hypersensitivity (DTH) as defined by delayed skin reactions to common recall antigens is generally depressed in RA, though the mechanism is obscure.24 For example, Emery and colleagues found that 36% of their patients with RA were anergic to seven recall antigens and that this appeared to be independent of both nutritional factors and clinical and serological indices which reflected disease activity.2 More recently they have speculated that this impairment of DTH was due to defective production of interleukin 2 by T lymphocytes in RA.5 In the present study we assessed DTH and other clinical and immunological indices at regular intervals in 31 patients with active RA and determined the influence of chrysotherapy on these measurements over 24 weeks of treatment. with the exception that B cells were enumerated according to the presence of surface membrane immunoglobulin. Monocytes in the peripheral blood mononuclear cell preparations were gated out and multiple analyses with FMC33 (a monoclonal antibody reacting with the monocyte/macrophage lineage) showed that these cells constituted <5% of the analysed lymphocytes. (Table 3) .
Discussion
The conclusions from this study are (a) there was a depression of DTH in patients with active RA, which was more marked in women; (b) there were no correlations between the DTH score at entry and other selected clinical, serological, and cellular indices; (c) there was a significant increase in the DTH score after 24 weeks of intramuscular gold; (d) this increase was observed in both the gold responders and the non-responders; (e) this increase was predominantly due to the return of DTH to tuberculin and candida in the women and to streptococcus in the men. A number of observers have noted a depression of cutaneous DTH in RA.25 In the current study 42% of the patients were anergic at entry, very similar to the 36% reported by Emery and colleagues,2 who used the same Multitest applicator to assess DTH. In both studies none of the control subjects were anergic, but in our studies these controls were not matched for age with the patients and were generally younger. The mean DTH score obtained for our controls was very similar, however, to that reported by Emery et al,2 whose control subjects were older (mean age 57 years) and were rheumatology patients with non-inflammatory joint diseases (mean (SD) DTH score of those patients was 18*0 (9.8) compared with 17-6 (6.2) for our younger control subjects).
Hence we feel that despite the younger age of our control group the results indicate a marked depression of DTH to these seven common recall antigens in our rheumatoid patients. The pathogenesis of this depression is still obscure, however.
A variety of non-specific and specific factors are known which influence the DTH response. interest was the observation that the DTH response to tuberculin in our rheumatoid male population was at all times, despite their active disease, greater than that seen for the healthy controls. There are several possible explanations for this, but one recent publication suggests it may be related to the presence of the major histocompatibility complex DR4 phenotype11 as such individuals are hyperreactive to tuberculin, and this phenotype would be strongly represented in our rheumatoid population. From our data the variable relating most obviously to the depressed DTH in RA was the female gender. Some investigators have speculated that the depressed DTH seen in RA may reflect a basic or intrinsic abnormality in the cellular immune arm in RA and have correlated it with depressed mononuclear cell proliferative responses in vitro, which are reversed by the addition of interleukin 2.5 We have also observed significantly impaired peripheral blood mononuclear cell mitogenic responses in vitro in patients with RA compared with matched controls (unpublished data). In these studies no consistent correlation was observed between mitogenic responses and gender in the peripheral blood but, of interest to the present study, women showed a significantly impaired mitogenic response with OKT3 in the synovial fluid compartment. Further studies to assess gender differences in DTH and mitogenic responses will be required to clarify this issue.
It was also observed that our female patients showed a higher T4/8 ratio than the men (p=0-06) at entry to the study, though age, disease activity, and other laboratory measurements were similar. Healthy women have significantly higher ratios than men,12 but we are unaware of this difference being noted before in RA.
The depression in DTH was reversed after 24 weeks' treatment with intramuscular gold, though this effect appeared to be relatively independent of the clinical efficacy of this treatment. Why gold should have this effect is not known. Current thought suggests that intramuscular gold may have its most important effects on cells of the monocytemacrophage lineage. It is possible that these cells and their cytokines could be defective in developing a normal DTH in RA and that gold corrects this disturbance. Further investigations along these lines are being pursued.
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